Eswatini vs Kenya: Access to anti-retroviral drugs, male
Eswatini
84.0%
in 2024
Kenya
84.0%
in 2024
Eswatini rank
36th
Kenya rank
36th
Access to anti-retroviral drugs, male over time
- Eswatini
- Kenya
How they compare
Eswatini currently reports 84.0% against 84.0% in Kenya, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Kenya ahead.
Eswatini ranks 36th and Kenya ranks 36th of 141 countries.
Kenya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 9.3% | 2.6% | Kenya |
| 2010s | 48.4% | 55.2% | 6.8% | Kenya |
| 2020s | 78.8% | 79.0% | 0.2% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Eswatini or Kenya?
- Eswatini, at 84.0% against 84.0% in Kenya as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Eswatini and Kenya?
- 0.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Kenya?
- 25 years are reported by both, from 2000 to 2024.
- How do Eswatini and Kenya rank globally for access to anti-retroviral drugs, male?
- Eswatini ranks 36th and Kenya ranks 36th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.